Activation of TLR4-mediated NFkappaB Signaling in Hemorrhagic Brain in Rats
Overview
Pathology
Authors
Affiliations
Inflammation and immunity play a crucial role in the pathogenesis of Intracerebral hemorrhage (ICH). Toll-like receptor 4- (TLR4-) mediated nuclear factor kappa-B (NFkappaB) signaling plays critical roles in the activation and regulation of inflammatory responses in injured brain. However, the involvement of TLR4-mediated NFkappaB signaling in the pathogenesis of ICH remains unknown. The present study was to evaluate the temporal profile of the expression of TLR4 and the activation of TLR4-mediated NFkappaB signaling in brain tissues of Wistar rats after ICH. TLR4 mRNA and protein, the phosphorylation of inhibitors of kappa B (p-IkappaBalpha), and the activity of NFkappaB were examined in hemorrhagic cerebral tissue by Rt-PCR, Western blots, immunohistochemistry staining, and EMSA. Compared with saline control, the TLR4 mRNA and protein significantly increased starting at 6 hours after ICH, peaked on the 3rd day after ICH, and then decreased but still maintained at a higher level on the 7th day after ICH (P < .05). The level of p-IkappaBalpha and the activity of NFkappaB also increased in the brain after ICH compared with saline control. The present study firstly suggests that TLR4-mediated NFkappaB signaling participates in the pathogenesis of ICH, which may become a therapeutic target for ICH-induced brain damage.
Wang Y, Xu M, Zuo X, Wang S, Yu Y, Gao Z Front Cell Dev Biol. 2025; 12:1509877.
PMID: 39902279 PMC: 11788306. DOI: 10.3389/fcell.2024.1509877.
Du Y, Wang J, Zhang J, Li N, Li G, Liu X CNS Neurosci Ther. 2024; 30(3):e14681.
PMID: 38516845 PMC: 10958402. DOI: 10.1111/cns.14681.
Nan C, Zhang Y, Zhang A, Shi Y, Yan D, Sun Z Mol Cell Biochem. 2024; 480(1):309-323.
PMID: 38459276 PMC: 11695394. DOI: 10.1007/s11010-024-04954-w.
Roy R, Mahmud F, Zayas J, Kuzel T, Reiser J, Shafikhani S J Invest Dermatol. 2023; 144(2):387-397.e11.
PMID: 37619833 PMC: 10840742. DOI: 10.1016/j.jid.2023.08.004.
de Sousa J, Azul F, de Araujo A, Tome R, Silva F, de Vasconcelos S Oxid Med Cell Longev. 2023; 2023:4752502.
PMID: 37151606 PMC: 10162877. DOI: 10.1155/2023/4752502.